Education
About Us
Working with TipRanks
Follow Us
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
RESEARCH TOOLSreports
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.56K | $ -7.51K | $ -3.80K | $ -2.42K | $ -13.09K |
| Operating Income | $ -7.19M | $ -15.69M | $ -13.19M | $ -6.23M | $ -4.13M |
| EBITDA | $ -7.08M | $ -15.75M | $ -13.18M | $ -6.21M | $ -3.35M |
| Net Income | $ -4.71M | $ -16.82K | $ -13.27M | $ -5.43M | $ -3.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.56M | $ 826.85K | $ 4.05M | $ 2.70M | $ 6.89M |
| Total Assets | $ 3.68M | $ 1.54M | $ 5.20M | $ 4.30M | $ 7.09M |
| Total Debt | $ 0.00 | $ 0.00 | $ 2.22M | $ 0.00 | $ 98.76K |
| Net Debt | $ -1.56M | $ -826.85K | $ -1.83M | $ -2.70M | $ -6.79M |
| Total Liabilities | $ 9.23M | $ 7.42M | $ 7.26M | $ 1.35M | $ 1.77M |
| Stockholders' Equity | $ -5.55M | $ -5.88M | $ -2.05M | $ 2.95M | $ 5.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.81M | $ -9.49M | $ -7.70M | $ -5.47M | $ -1.61M |
| Operating Cash Flow | $ -1.81M | $ -9.49M | $ -7.70M | $ -5.47M | $ -1.60M |
| Investing Cash Flow | $ -1.21K | $ 0.00 | $ -5.92K | $ -1.67K | $ -18.11K |
| Financing Cash Flow | $ 2.66M | $ 6.21M | $ 9.32M | $ 2.15M | $ 7.83M |